Possible role for human leukocyte antigen haplotype in rofecoxib-associated acute pancreatitis and cholestatic hepatitis.
Sato
Ken
K
Yamada
Eijirou
E
Uehara
Yutaka
Y
Takagi
Hitoshi
H
Mori
Masatomo
M
D000368:Aged; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced* / Q000235:genetics; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006680:HLA Antigens / Q000235:genetics*; D006239:Haplotypes / Q000235:genetics*; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy; D019283:Pancreatitis, Acute Necrotizing / Q000139:chemically induced* / Q000235:genetics; D013450:Sulfones / Q000009:adverse effects* / Q000627:therapeutic use
D052246:Cyclooxygenase 2 Inhibitors; D006680:HLA Antigens; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib